Eric Richman

Eric Richman has extensive experience in the biotechnology and healthcare sectors, currently serving as an Independent Director at SafeHeal, LabConnect, PolarityTE, MicroHealth, and Tempo Therapeutics, while also holding the position of Director at Gain Therapeutics. Previously, Eric was a Director and Co-Founder at Horizon Infusions/InFuse Holdings, and served as a Director at ADMA Biologics, Inc. Eric's earlier roles include Venture Partner at Brace Pharma Capital and President & CEO at PharmAthene, Inc. Eric holds a Bachelor of Science degree in Biomedical Science from CUNY School of Medicine and an MBA in Finance and International Marketing from Thunderbird School of Global Management.